HUMAN METAPNEUMOVIRUS INFECTION

Clinical trials for HUMAN METAPNEUMOVIRUS INFECTION explained in plain language.

Never miss a new study

Get alerted when new HUMAN METAPNEUMOVIRUS INFECTION trials appear

Sign up with your email to follow new studies for HUMAN METAPNEUMOVIRUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New Triple-Threat vaccine aims to shield seniors from three winter viruses

⭐️ VACCINE ⭐️ Ongoing

This study tests two new vaccines (SCB-1022 and SCB-1033) designed to protect against RSV, human metapneumovirus, and parainfluenza virus. Researchers will enroll 612 healthy adults aged 60-85 to check safety and immune response. The goal is to see if combining protection against…

Matched conditions: HUMAN METAPNEUMOVIRUS INFECTION

Phase: PHASE1, PHASE2 • Sponsor: Clover Biopharmaceuticals AUS Pty • Aim: ⭐️ VACCINE ⭐️

Last updated May 17, 2026 10:40 UTC

HUMAN METAPNEUMOVIRUS INFECTION

Get alerted when new HUMAN METAPNEUMOVIRUS INFECTION trials appear

New Triple-Threat vaccine aims to shield seniors from three winter viruses